dc.creatorBassani, Mariana A
dc.creatorde Oliveira, Ana Beatriz F
dc.creatorOliveira Neto, Antonio F
dc.date2009-Jul
dc.date2015-11-27T13:15:21Z
dc.date2015-11-27T13:15:21Z
dc.date.accessioned2018-03-29T01:09:04Z
dc.date.available2018-03-29T01:09:04Z
dc.identifierRespiratory Care. v. 54, n. 7, p. 969-72, 2009-Jul.
dc.identifier0020-1324
dc.identifier
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/19558746
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/198381
dc.identifier19558746
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1298614
dc.descriptionWe saw a 34-year-old pregnant woman with acute promyelocytic leukemia, who developed acute respiratory failure from all-trans-retinoic acid (ATRA) syndrome. We applied noninvasive ventilation (NIV, continuous positive airway pressure plus pressure-support ventilation) to try to improve gas exchange, reduce the work of breathing, and prevent intubation. Initially we applied NIV continuously (24 hours a day), then gradually reduced the daily amount of time on NIV as her condition improved. She was discharged from the intensive care unit after 12 days. Three months after hospital discharge she gave vaginal birth to a healthy female baby. NIV was effective and safe for the mother and fetus, and NIV should be considered for respiratory failure in pregnant patients, especially if immunosuppressed.
dc.description54
dc.description969-72
dc.languageeng
dc.relationRespiratory Care
dc.relationRespir Care
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAntineoplastic Agents
dc.subjectFemale
dc.subjectHumans
dc.subjectLeukemia, Myeloid, Acute
dc.subjectPregnancy
dc.subjectPregnancy Complications, Neoplastic
dc.subjectRespiration, Artificial
dc.subjectRespiratory Insufficiency
dc.subjectSyndrome
dc.subjectTretinoin
dc.titleNoninvasive Ventilation In A Pregnant Patient With Respiratory Failure From All-trans-retinoic-acid (atra) Syndrome.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución